Kinetics and mechanism of hydrolysis of efavirenz

被引:38
作者
Maurin, MB [1 ]
Rowe, SM
Blom, K
Pierce, ME
机构
[1] DuPont Pharmaceut Co, Pharm R&D, Wilmington, DE 19880 USA
[2] DuPont Pharmaceut Co, Chem & Phys Sci, Wilmington, DE 19880 USA
[3] DuPont Pharmaceut Co, Chem Proc R&D, Deepwater, NJ USA
关键词
efavirenz; solution stability; carbamate hydrolysis;
D O I
10.1023/A:1015160132290
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To determine the kinetics and mechanism of hydrolysis of efavirenz [(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one] in aqueous solutions. Methods. The solution stability was examined at 60degreesC and an ionic strength of 0.3 M over the pH range of 0.6 to 12.8. The loss of efavirenz and the appearance of degradants were followed with a reverse-phase high-performance liquid chromatography assay. Characterization of the degradants was accomplished with liquid chromatography-mass spectrometry. Results. The degradation of efavirenz followed apparent first-order kinetics over the pH range of 0.6 to 12.8 at 60degreesC. The catalytic effect of phosphate and borate buffers was negligible while acetate and citrate demonstrated buffer catalysis. The overall rate constant indicated a pH minimum (the pH of maximum stability) of approximately 4. Mass spectra data identified a degradant with a molecular weight consistent with hydrolysis of the cyclic carbamate to the corresponding amino alcohol. The degradation route was confirmed with spiking experiments with an authentic sample of the amino alcohol indicating that the carbamate hydrolysis pathway was the predominant reaction throughout the pH range studied. Subsequent degradation of the amino alcohol proceeded at the extremes of the pH range studied via rearrangement to the quinoline. Conclusions. The pH-rate profile was consistent with a combination of a V-shaped profile in the pH range of 0-9 and a sigmoid-shaped profile in the pH range of 4-13. The plateau that began at pH 10-11 is a result of the ionization of the amine of the carbamate inhibiting the base-catalyzed hydrolysis of efavirenz, given that the ionized form of the carbamate is resonance-stabilized toward hydroxide-catalyzed degradation. Thus, increasing the pH resulted in a parallel decrease in the unionized fraction and increase in hydroxide ion concentration resulting in a constant k(o)bs value.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 13 条
[1]  
ALBRECHT M, 1999, 6 C RETR OPP INF
[2]   HIV INHIBITORS TARGETED AT THE REVERSE-TRANSCRIPTASE [J].
DECLERCQ, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :119-137
[3]  
Picquet M, 2000, EUR J ORG CHEM, V2000, P2361, DOI 10.1002/1099-0690(200007)2000:13<2361::AID-EJOC2361>3.0.CO
[4]  
2-S
[5]   Practical asymmetric synthesis of efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor [J].
Pierce, ME ;
Parsons, RL ;
Radesca, LA ;
Lo, YS ;
Silverman, S ;
Moore, JR ;
Islam, Q ;
Choudhury, A ;
Fortunak, JMD ;
Nguyen, D ;
Luo, C ;
Morgan, SJ ;
Davis, WP ;
Confalone, PN ;
Chen, CY ;
Tillyer, RD ;
Frey, L ;
Tan, LS ;
Xu, F ;
Zhao, DL ;
Thompson, AS ;
Corley, EG ;
Grabowski, EJJ ;
Reamer, R ;
Reider, PJ .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (23) :8536-8543
[6]  
Rabel S R, 1996, Pharm Dev Technol, V1, P91, DOI 10.3109/10837459609031422
[7]   Synthesis of HIV-1 reverse transcriptase inhibitor DMP 266 [J].
Radesca, LA ;
Lo, YS ;
Moore, JR ;
Pierce, ME .
SYNTHETIC COMMUNICATIONS, 1997, 27 (24) :4373-4384
[8]  
ROWE SM, 1999, AAPS PHARMSCI S
[9]   MECHANISM OF INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS [J].
SPENCE, RA ;
KATI, WM ;
ANDERSON, KS ;
JOHNSON, KA .
SCIENCE, 1995, 267 (5200) :988-993
[10]   Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].
Staszewski, S ;
Morales-Ramirez, J ;
Tashima, KT ;
Rachlis, A ;
Skiest, D ;
Stanford, J ;
Stryker, R ;
Johnson, P ;
Labriola, DF ;
Farina, D ;
Manion, DJ ;
Ruiz, NM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873